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mimicking renal cell carcinomaDear Editor,
Metastasis of hepatocellular carcinoma (HCC) can involve
many organs, but rarely occurs in the kidney. We report a
case of HCC with rare kidney metastasis.
A79-year-old male patient with a past history of only
hypertension presented with left abdominal pain for 2Figure 1. (A) T2-weighted abdominal magnetic resonance imagin
mass of left kidney (red arrow); both with intermediate signal inten
tumor cells with eosinophilic cytoplasm arranging in a solid pattern,
showed negative for renal cell carcinoma antigen. (D) The immunoh
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symptoms included poor appetite and weight loss. He was a
nonsmoker and did not consume alcohol. The initial
biochemistry analysis was abnormal only in hemoglobin
(11.4 g/dL) and serum creatinine (2.24 mg/dL). An
abdominal ultrasound revealed a 6-cm low echoic tumorg showed a right hepatic mass (white arrow) and an exophytic
sity. (B) Pathology of the left kidney mass showed pleomorphic
typical presentation of HCC. (C) The immunohistochemical study
istochemical study showed positive for hepatocyte paraffin 1.
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+ MODELover the left kidney and a 9-cm mixed echoic tumor at the
right hepatic lobe. Serum alpha-fetoprotein (AFP) level was
within normal limits. A virological exam was negative for
hepatitis B surface antigen and hepatitis C antibody.
Magnetic resonance imaging also showed tumors in the
left kidney and right hepatic lobe with intermediate
signal intensity on T2-weighted and T1-weighted images
(Figure 1A). The tumors also showed significant water
diffusion restriction and heterogeneous enhancement in a
dynamic contrast study. The radiologist diagnosis was renal
cell carcinoma with hepatic metastasis. A computed
tomography-guided biopsy of the left kidney tumor was
performed. An immunohistochemical study of the tumor
tissue showed that the tumor cells were negative for
renal cell carcinoma antigen, carcinoembryonic antigen,
glypican-3, and CK7, but positive for hepatocyte paraffin 1
and CD10 (canalicular pattern) (Figures 1Be1D). Metastatic
HCC was diagnosed by pathology. After confirmation of
metastatic HCC, targeted therapy with sorafenib was pre-
scribed. The patient is currently alive and has been taking
sorafenib for 2 months.
HCC metastasis to the kidney has been rarely reported
[1e5]. The most frequent sites of metastasis were the lung,
regional lymph nodes, and musculoskeletal region. Renal
metastasis from HCC is usually unilateral and does not favor
the right or left side, based on our case and previous re-
ports (3 cases renal metastasis on the right side and 4 cases
on the left side) [1e5]. The renal metastases are not similar
to those from other solid organ tumors, which are generally
small, bilateral, and multifocal. Renal function may be
normal or impaired upon diagnosis, according to case re-
ports (including ours) [1]. AFP may be normal or highly
elevated, but highly elevated AFP may further ensure the
diagnosis of HCC [1].
It is difficult to distinguish metastatic renal tumors
from primary renal tumors. Contrast-enhanced image
modalities such as computed tomography or magnetic
resonance imaging may help to distinguish these tumors
because HCC has a typical enhanced pattern with early
enhancement at the arterial phase and early wash out at
the portal venous phase. AFP level can also be a dis-
tinguishing factor, as AFP level will only be elevated in
HCC, but not in primary renal tumor. However, becausePlease cite this article in press as: Jang T-Y, Yeh M-L, Hepatocellular
Kaohsiung Journal of Medical Sciences (2016), http://dx.doi.org/10.1the typical HCC enhanced pattern was not present and
AFP level was normal in our case, the initial diagnosis was
primary renal tumor with hepatic metastasis. Pathological
diagnosis via core needle biopsy or surgery is usually
necessary under this situation. Once a diagnosis of HCC
with kidney metastasis is made, the prognosis for most
patients is extremely poor and sorafenib is the preferred
treatment.
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